UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000014085
Receipt number R000016394
Scientific Title Effect of Lactobacillus brevis KB290 on constipation and on microbiota of people who tend to be constipated.
Date of disclosure of the study information 2014/05/30
Last modified on 2015/05/13 08:56:08

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of Lactobacillus brevis KB290 on constipation and on microbiota of people who tend to be constipated.

Acronym

Effect of Lactobacillus brevis KB290 on constipation and on microbiota of people who tend to be constipated.

Scientific Title

Effect of Lactobacillus brevis KB290 on constipation and on microbiota of people who tend to be constipated.

Scientific Title:Acronym

Effect of Lactobacillus brevis KB290 on constipation and on microbiota of people who tend to be constipated.

Region

Japan


Condition

Condition

people tend to be constipated

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The status of bowel movement before and after the intervention with probiotics, Lactobacillus brevis KB290, as a lactic acid bacteria beverage, Labre, will be compared. Also, the effect of Labre on microbiota will be evaluated cyclopaedically using latest analysis methods and figure out the relation between microbiota and health.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Defecation frequency, days of defecation frequency in a week, amount of defecation, hardness of stool and amount of organic acid in stool will be measured.
Also, the amount of bacteria related
with bowel movement, which are Bacteroidaceae, Enterobacteriaceae, Streptococcaceae, Bifidobacterium genus,
Eubacterium genus, Peptostreptococcus genus, Lactobacillus genus, Clostridium perfringens and other bacteria belongs to Clostridium genus, will be measured.

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Non-randomized

Randomization unit


Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Lactic acid beverage containing Lactobacillus brevis KB290

Interventions/Control_2

Placebo beverage

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

People who meet either of the following conditions will be required.
1)Whose defecation frequency is no fewer than 2, nor more than 5.
2)Whose appearance frequency of hard
stool (stools which match Bristol scale score 1, 2 or 3) is 50% and over.

Key exclusion criteria

People who meet any of the following conditions will be excluded.
1)Who is judged as unsuitable because of having suffered a serious disease so far.
2)Who takes any kind of medicine which affect the result of the trial for habitual use.
3)Who has undergone surgery accompanied with digestive tract ablation.
4)Who has participated in another clinical trial within 1 month.
5)Who is judged unsuitable for this study by principal investigator.

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Nobuhiro Yajima

Organization

Kagome Co., Ltd.

Division name

Research & Development Division

Zip code


Address

17 Nishitomiyama, Nasushiobarashi, Tochigi, 329-2762, Japan

TEL

0287-36-2935

Email

Nobuhiro_Yajima@kagome.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Akira Kobayashi

Organization

Kagome Co., Ltd.

Division name

Research & Development Division

Zip code


Address

17 Nishitomiyama, Nasushiobarashi, Tochigi, 329-2762, Japan

TEL

0287-36-2935

Homepage URL


Email

Akira_Kobayashi@kagome.co.jp


Sponsor or person

Institute

Kagome Co., Ltd.

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

transcosmos CRM okinawa Co., Ltd.

Name of secondary funder(s)

Urazoe General Hospital


IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2014 Year 05 Month 30 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 30 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete

2015 Year 02 Month 26 Day

Date analysis concluded

2015 Year 03 Month 31 Day


Other

Other related information



Management information

Registered date

2014 Year 05 Month 27 Day

Last modified on

2015 Year 05 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016394


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name